Cowen analyst Joseph Thome reiterated an Outperform rating on Intellia Therapeutics (NASDAQ: NTLA) and named it a Best Smidcap idea.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE